The New York Times | Zantac Products Should Not Be Sold or Used, F.D.A. Warns, Citing Cancer Danger

The New York Times released an article titled, "Zantac Products Should Not Be Sold or Used, F.D.A. Warns, Citing Cancer Danger." This article highlights how FDA concluded that a potential cancer-causing contaminant can build up in the heartburn drug Zantac when stored for long periods. The FDA's investigation was prompted by Valisure's findings if high levels of NDMA in ranitidine.

View the full article via The New York Times here.

The New York Times | Zantac Products Should Not Be Sold or Used, F.D.A. Warns, Citing Cancer Danger

April 1, 2020

The New York Times released an article titled, "Zantac Products Should Not Be Sold or Used, F.D.A. Warns, Citing Cancer Danger." This article highlights how FDA concluded that a potential cancer-causing contaminant can build up in the heartburn drug Zantac when stored for long periods. The FDA's investigation was prompted by Valisure's findings if high levels of NDMA in ranitidine.

View the full article via The New York Times here.

The New York Times | Zantac Products Should Not Be Sold or Used, F.D.A. Warns, Citing Cancer Danger

The New York Times released an article titled, "Zantac Products Should Not Be Sold or Used, F.D.A. Warns, Citing Cancer Danger." This article highlights how FDA concluded that a potential cancer-causing contaminant can build up in the heartburn drug Zantac when stored for long periods. The FDA's investigation was prompted by Valisure's findings if high levels of NDMA in ranitidine.

View the full article via The New York Times here.

The New York Times released an article titled, "Zantac Products Should Not Be Sold or Used, F.D.A. Warns, Citing Cancer Danger." This article highlights how FDA concluded that a potential cancer-causing contaminant can build up in the heartburn drug Zantac when stored for long periods. The FDA's investigation was prompted by Valisure's findings if high levels of NDMA in ranitidine.

View the full article via The New York Times here.

SIGN UP FOR THE VALISURE NEWSLETTER 

Sign up to stay updated with Valisure announcements, relevant industry news, company updates, and more. 

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.